BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

GlobeNewswire
2025.11.25 13:33
portai
I'm PortAI, I can summarize articles.

PHILADELPHIA and VANCOUVER, British Columbia, Nov. 25, 2025 ( GLOBE NEWSWIRE ) -- BriaCell Therapeutics Corp. ( Nasdaq: BCTX, BCTXW ) ( TSX: BCT ) ( "BriaCell" or the "Company" ) , a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, will present ...

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer